Kyowa Kirin KK

4151

Equity

ISIN JP3256000005 / Valor 762410

Tokyo Stock Exchange (2024-12-25)

JPY 2,379.50-0.27%

Kyowa Kirin KK
UMushroom community rating:

0.00 0 votes No rating yet

NegativeNeutralPositive

About company

Kyowa Kirin Co., Ltd. is a Japan-based global specialty pharmaceutical company focused on addressing unmet medical needs through the development and delivery of innovative pharmaceuticals. The company leverages a diverse team of experts dedicated to creating life-changing treatments for diseases that currently lack effective solutions. Kyowa Kirin's portfolio includes a range of products aimed at improving patient outcomes and enhancing quality of life. By continuously advancing life sciences and technologies, the company strives to contribute to global health and well-being.

Summarized from source with an LLMView SourceSector: Industrials

Revenue Growth

In the third quarter of 2023, Kyowa Kirin KK reported a significant increase in revenue, reaching 362.8 billion yen, up from 306.1 billion yen in the same period of the previous year. This represents a 19% year-over-year growth, driven by strong performance in international markets, particularly in North America and EMEA regions.

Regional Performance

Kyowa Kirin KK's revenue in North America surged by 29%, largely due to the growth of key products like Crysvita and Poteligeo. The EMEA region also saw a substantial increase of 44%, supported by the growth of Crysvita and Poteligeo, as well as the IP transfer of established medicines to Grünenthal-Med.

Core Operating Profit

The company's core operating profit for Q3 2023 was 74.4 billion yen, marking a 22% increase from the previous year. This growth was attributed to the rise in revenue, although the gross profit margin slightly declined due to increased costs of goods sold, particularly in North America.

Profit and Dividends

Kyowa Kirin KK's profit for the first nine months of 2023 increased by 2.3 billion yen. Despite some financial restructuring expenses and impairment losses, the company managed to maintain a positive profit trajectory, reflecting its strategic focus on core operations and market expansion.

Future Outlook

Looking ahead, Kyowa Kirin KK plans to continue strengthening its market presence through evidence-based marketing activities and geographical expansion. The company aims to enhance disease awareness and optimize its field team structure in North America, while focusing on market penetration in EMEA and Japan.

Summarized from source with an LLMView Source

Key figures

1.23%1Y

-25.8%3Y

-6.21%5Y

Performance

32.9%1Y

28.4%3Y

29.2%5Y

Volatility